LEWIS JOEL bought GALT
January 16, 2026 · Form 4 insider transaction
LEWIS JOEL bought 120,000 shares of Galectin Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$0.00
Total value
N/A
InsiderLEWIS JOEL
RoleOfficer, Director
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.; The Restricted Stock Units, if vested, convert into Common Stock on a one for one basis.; Restricted Stock Units vest 100% on the earlier of December 31, 2026 or signing of a partnership agreement.